ARTERRA BIOSCIENCE (ARBS.MI)

EUR 2.24

(0.0%)

Operating Expenses Summary of ARTERRA BIOSCIENCE

ARTERRA BIOSCIENCE's latest annual operating expenses in 2023 was 3.38 Million EUR , down -1077.94% from previous year.
ARTERRA BIOSCIENCE's latest quarterly operating expenses in 2024 Q2 was 897.24 Thousand EUR , down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported a annual operating expenses of 127.74 Thousand EUR in annual operating expenses 2022, down -32.67% from previous year.
ARTERRA BIOSCIENCE reported a annual operating expenses of 189.72 Thousand EUR in annual operating expenses 2021, up 4.95% from previous year.
ARTERRA BIOSCIENCE reported a quarterly operating expenses of 329.86 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported a quarterly operating expenses of -1.24 Million EUR for 2023 FY, down -1077.94% from previous quarter.

Annual Operating Expenses Chart of ARTERRA BIOSCIENCE (2023 - 2017)

Historical Annual Operating Expenses of ARTERRA BIOSCIENCE (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	3.38 Million EUR	-1077.94%
2022	127.74 Thousand EUR	-32.67%
2021	189.72 Thousand EUR	4.95%
2020	180.78 Thousand EUR	-1.67%
2019	183.84 Thousand EUR	-7.69%
2018	199.16 Thousand EUR	19.98%
2017	166 Thousand EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	897.24 Thousand EUR	0.0%
2023 Q4	329.86 Thousand EUR	0.0%
2023 FY	-1.24 Million EUR	-1077.94%
2023 Q2	65.08 Thousand EUR	0.0%
2022 FY	127.74 Thousand EUR	-32.67%
2022 Q2	71.62 Thousand EUR	0.0%
2022 Q4	62.02 Thousand EUR	0.0%
2021 Q2	85.55 Thousand EUR	0.0%
2021 FY	189.72 Thousand EUR	4.95%
2021 Q4	256.13 Thousand EUR	0.0%
2020 Q4	96.87 Thousand EUR	0.0%
2020 Q2	83.9 Thousand EUR	0.0%
2020 FY	180.78 Thousand EUR	-1.67%
2019 Q3	574.61 Thousand EUR	67.36%
2019 FY	183.84 Thousand EUR	-7.69%
2019 Q4	85.18 Thousand EUR	-85.18%
2019 Q2	343.35 Thousand EUR	0.0%
2018 Q4	88.95 Thousand EUR	0.0%
2018 FY	199.16 Thousand EUR	19.98%
2018 Q2	244.38 Thousand EUR	0.0%
2017 FY	166 Thousand EUR	0.0%

Peer Operating Expenses Comparison of ARTERRA BIOSCIENCE

Name	Operating Expenses	Operating Expenses Difference
Philogen S.p.A.	14.5 Million EUR	76.676%
Ulisse Biomed S.p.A.	1.91 Million EUR	-77.177%